PATIENTS WITH BONE METASTASES OR A HISTORY OF SKELETAL MALIGNANCIES & METABOLIC BONE DISEASES OTHER THAN OSTEOPOROSIS SHOULD BE EXCLUDED FROM TREATMENT.
20 MICROGRAMS IS GIVEN SUBCUTANEOUSLY DAILY INTO THE THIGH OR ABDOMINAL WALL. TREATMENT IS LIMITED TO A MAXIMUM OF 18 MONTHS IN THE UK, ALTHOUGH IT HAS BEEN USED FOR UP TO 2 YEARS IN THE USA. TERIPARATIDE ACETATE HAS BEEN GIVEN BY INTRAVENOUS INFUSION IN THE DIFFERENTIAL DIAGNOSIS OF HYPOPARATHYROIDISM AND PSEUDOHYPOPARATHYROIDISM.